Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check7 days agoChange DetectedThe page has been updated to reflect a new version (v2.16.5) and the posting of results, while previous dates and version information have been removed.SummaryDifference5%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.